Schedule 13G ownership disclosure
Pacific Biosciences of California Inc
Common Stock, par value $0.001 · CUSIP: 69404D108
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Madrone Capital Partners, LLC
Shares: 16,762,216.00 · Class: 5.6%
- Madrone Opportunity Fund, L.P.
Shares: 16,762,216.00 · Class: 5.6%
- Shimoda Holdings, LLC
Shares: 3,500,000.00 · Class: 1.2%
- Gregory Boyd Penner
Shares: 20,262,216.00 · Class: 6.8%
- Jameson J. McJunkin
Shares: 16,762,216.00 · Class: 5.6%
- Thomas Patterson
Shares: 16,762,216.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021671
- Form type
- SCHEDULE 13G/A
- Filer
- MADRONE CAPITAL PARTNERS, LLC
- CIK
- CIK 1789147
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership